These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33529569)

  • 21. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.
    Rostami A; Sepidarkish M; Leeflang MMG; Riahi SM; Nourollahpour Shiadeh M; Esfandyari S; Mokdad AH; Hotez PJ; Gasser RB
    Clin Microbiol Infect; 2021 Mar; 27(3):331-340. PubMed ID: 33228974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients.
    Del Zompo F; De Maio F; Santopaolo F; Ricci R; Gasbarrini A; Pompili M; Ponziani FR
    Dig Liver Dis; 2021 May; 53(5):541-544. PubMed ID: 33707148
    [No Abstract]   [Full Text] [Related]  

  • 23. Postvaccination COVID-19 among Healthcare Workers, Israel.
    Amit S; Beni SA; Biber A; Grinberg A; Leshem E; Regev-Yochay G
    Emerg Infect Dis; 2021 Apr; 27(4):1220-1222. PubMed ID: 33522478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis.
    Berardis S; Verroken A; Vetillart A; Struyf C; Gilbert M; Gruson D; Gohy S
    J Cyst Fibros; 2020 Nov; 19(6):872-874. PubMed ID: 32828701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Outbreak Dynamics in an Isolated US Military Recruit Training Center With Rigorous Prevention Measures.
    Lizewski RA; Sealfon RSG; Park SW; Smith GR; Porter CK; Gonzalez-Reiche AS; Ge Y; Miller CM; Goforth CW; Pincas H; Termini MS; Ramos I; Nair VD; Lizewski SE; Alshammary H; Cer RZ; Chen HW; George MC; Arnold CE; Glang LA; Long KA; Malagon F; Marayag JJ; Nunez E; Rice GK; Santa Ana E; Schilling MA; Smith DR; Sugiharto VA; Sun P; van de Guchte A; Khan Z; Dutta J; Vangeti S; Voegtly LJ; Weir DL; Metcalf CJE; Troyanskaya OG; Bishop-Lilly KA; Grenfell BT; van Bakel H; Letizia AG; Sealfon SC
    Epidemiology; 2022 Nov; 33(6):797-807. PubMed ID: 35944149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dried Blood Spot as an Alternative to Plasma/Serum for SARS-CoV-2 IgG Detection, an Opportunity to Be Sized to Facilitate COVID-19 Surveillance Among Schoolchildren.
    Amendola A; Bianchi S; Gori M; Barcellini L; Colzani D; Canuti M; Giacomet V; Fabiano V; Folgori L; Zuccotti GV; Tanzi E
    Pediatr Infect Dis J; 2021 Jan; 40(1):e46-e47. PubMed ID: 33181785
    [No Abstract]   [Full Text] [Related]  

  • 27. SARS-CoV-2 Seroprevalence and Symptom Onset in Culturally Linked Orthodox Jewish Communities Across Multiple Regions in the United States.
    Zyskind I; Rosenberg AZ; Zimmerman J; Naiditch H; Glatt AE; Pinter A; Theel ES; Joyner MJ; Hill DA; Lieberman MR; Bigajer E; Stok D; Frank E; Silverberg JI
    JAMA Netw Open; 2021 Mar; 4(3):e212816. PubMed ID: 33688968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020.
    Sami S; Akinbami LJ; Petersen LR; Crawley A; Lukacs SL; Weiss D; Henseler RA; Vuong N; Mackey L; Patel A; Grohskopf LA; Morgenthau BM; Daskalakis D; Pathela P
    Emerg Infect Dis; 2021 Mar; 27(3):796-804. PubMed ID: 33493106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
    Pathela P; Crawley A; Weiss D; Maldin B; Cornell J; Purdin J; Schumacher PK; Marovich S; Li J; Daskalakis D;
    J Infect Dis; 2021 Jul; 224(2):196-206. PubMed ID: 33836067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study.
    Ebinger JE; Botwin GJ; Albert CM; Alotaibi M; Arditi M; Berg AH; Binek A; Botting P; Fert-Bober J; Figueiredo JC; Grein JD; Hasan W; Henglin M; Hussain SK; Jain M; Joung S; Karin M; Kim EH; Li D; Liu Y; Luong E; McGovern DPB; Merchant A; Merin N; Miles PB; Minissian M; Nguyen TT; Raedschelders K; Rashid MA; Riera CE; Riggs RV; Sharma S; Sternbach S; Sun N; Tourtellotte WG; Van Eyk JE; Sobhani K; Braun JG; Cheng S
    BMJ Open; 2021 Feb; 11(2):e043584. PubMed ID: 33579769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid coronavirus tests: a guide for the perplexed.
    Guglielmi G
    Nature; 2021 Feb; 590(7845):202-205. PubMed ID: 33564189
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities.
    Orner EP; Rodgers MA; Hock K; Tang MS; Taylor R; Gardiner M; Olivo A; Fox A; Prostko J; Cloherty G; Farnsworth CW
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115300. PubMed ID: 33388575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia.
    Pavelka M; Van-Zandvoort K; Abbott S; Sherratt K; Majdan M; ; ; Jarčuška P; Krajčí M; Flasche S; Funk S
    Science; 2021 May; 372(6542):635-641. PubMed ID: 33758017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia.
    Rogawski McQuade ET; Guertin KA; Becker L; Operario D; Gratz J; Guan D; Khan F; White J; McMurry TL; Shah B; Garofalo S; Southerland M; Bear K; Brush J; Allen C; Frayser A; Vokes R; Pershad R; Peake L; deFilippi C; Barackman K; Bearman G; Bidanset A; Farrell F; Trump D; Houpt ER
    JAMA Netw Open; 2021 Feb; 4(2):e2035234. PubMed ID: 33555331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut.
    Mahajan S; Caraballo C; Li SX; Dong Y; Chen L; Huston SK; Srinivasan R; Redlich CA; Ko AI; Faust JS; Forman HP; Krumholz HM
    Am J Med; 2021 Jun; 134(6):812-816.e2. PubMed ID: 33617808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 39. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.